Owkin
a federated-learning AI company that, in a Nature Medicine report, trained deep-learning models on multi-hospital histopathology data without sharing patient slides, and pursues generalizable pathology, spatial transcriptomics and agentic AI co-pilots for researchers.
- Country
- France
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| AI pathology interpretation (computational pathology) | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.